| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 643915 | Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- | 0.0490935610249072 | 0.2991147 |
| NSC 658387 | 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- | 0.0490935610249072 | 0.4906779 |
| NSC 665883 | Null | 0.0490935610249072 | -0.065554668 |
| NSC 683247 | Acridine-4-carboxamide, 9-amino-5-methyl- N-[2-(dimethylamino)ethyl]-, dihydrochloride | 0.0490935610249072 | 0.14149162 |
| NSC 685865 | Null | 0.0490935610249072 | -0.13926369 |
| NSC 702045 | 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- | 0.0490935610249072 | 0.56338681 |
| NSC 723906 | 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline | 0.0490935610249072 | 0.56952726 |
| NSC 740252 | Null | 0.0490935610249072 | 0.38748068 |
| NSC 750970 | 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone | 0.0490935610249072 | -0.27903839 |
| NSC 756140 | GSK1220512A | 0.0490935610249072 | 0.063040011 |